These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33349878)
1. The role of medicine donations in the global programme for the elimination of lymphatic filariasis. Williams T; Taylor R; Iwamoto M; Hida T; Gusovsky F Int Health; 2020 Dec; 13(Suppl 1):S39-S43. PubMed ID: 33349878 [TBL] [Abstract][Full Text] [Related]
2. Elimination of lymphatic filariasis as a public health problem in Malawi. Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794 [TBL] [Abstract][Full Text] [Related]
3. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000). Ottesen EA; Horton J Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877 [TBL] [Abstract][Full Text] [Related]
4. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. Gustavsen KM; Bradley MH; Wright AL Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393 [TBL] [Abstract][Full Text] [Related]
5. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis. Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883 [TBL] [Abstract][Full Text] [Related]
6. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis. Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843 [TBL] [Abstract][Full Text] [Related]
7. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228 [TBL] [Abstract][Full Text] [Related]
8. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis. Devi RR; Raju V J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444 [TBL] [Abstract][Full Text] [Related]
9. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China. Fang Y; Zhang Y Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644 [TBL] [Abstract][Full Text] [Related]
10. How Thailand eliminated lymphatic filariasis as a public health problem. Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143 [TBL] [Abstract][Full Text] [Related]
12. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020). Turner HC; Ottesen EA; Bradley MH Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508 [TBL] [Abstract][Full Text] [Related]
13. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt. Ramzy RMR; Kamal HA; Hassan MA; Haggag AA Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299 [TBL] [Abstract][Full Text] [Related]
14. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis. Krentel A; Gyapong M; McFarland DA; Ogundahunsi O; Titaley CR; Addiss DG Int Health; 2020 Dec; 13(Supplement_1):S55-S59. PubMed ID: 33349882 [TBL] [Abstract][Full Text] [Related]
15. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs. Gedge LM; Bettis AA; Bradley MH; Hollingsworth TD; Turner HC Parasit Vectors; 2018 Feb; 11(1):75. PubMed ID: 29391042 [TBL] [Abstract][Full Text] [Related]
16. Elimination of lymphatic filariasis: do we have the drugs to complete the job? Bockarie MJ; Deb RM Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694 [TBL] [Abstract][Full Text] [Related]
17. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Houston R Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687 [TBL] [Abstract][Full Text] [Related]
18. The global programme to eliminate lymphatic filariasis. Ottesen EA Trop Med Int Health; 2000 Sep; 5(9):591-4. PubMed ID: 11044272 [TBL] [Abstract][Full Text] [Related]
19. Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination. El Setouhy M; Ramzy RM East Mediterr Health J; 2003 Jul; 9(4):534-41. PubMed ID: 15748050 [TBL] [Abstract][Full Text] [Related]
20. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination. Alexander ND Trans R Soc Trop Med Hyg; 2015 Mar; 109(3):173-4. PubMed ID: 25575555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]